Skip to main content
Skip to main content
Go to homepage

Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma

Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma

Description:

Please visit clinicaltrials.gov for complete study information.

Study Status:
Closed
IRB Study ID:
100608
If you are interested in this study or have questions about your child's eligibility, please contact:
Rebecca D. Considine Research Institute, 330-543-3193 or email research@akronchildrens.org
Lead Investigator
Steven Kuerbitz, MD

Director, Divisional Research, Shannon E. Wilkes Targeted Therapy Program; The Jeffrey A. Barbour Chair for Pediatric Hematology/Oncology Research and Healing; Pediatric Hematologist-Oncologist
Showers Family Center for Childhood Cancer and Blood DisordersPediatric Stem Cell Transplant Program

By using this site, you consent to our use of cookies. To learn more, read our privacy policy.